March 18, 2019

FDA: Hospira recalls 8.4% Sodium Bicarbonate Injection

By: Judy Mathias

Editor’s Note

The Food and Drug Administration (FDA) on March 15 announced the recall by Hospira, Inc (a Pfizer company) of three lots of its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL).

The recall was initiated because of the presence of particulate matter, confirmed as glass.

The lots and expiration dates are:

  • 79-238-EV (Exp July 1, 2019)
  • 79-240-EV (Exp July 1, 2019)
  • 80-088-EV (Exp August 1, 2019).

The affected lots were distributed from August 2017 to September 2017.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat